Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow changed -95.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Gross margin changed +7791 basis points from the comparable as-filed period.
Operating margin changed +147037 basis points from the comparable as-filed period.
Current assets changed +110.3% from the comparable as-filed period.
Shares outstanding changed +37.0% from the comparable as-filed period.
Total assets changed +114.0% from the comparable as-filed period.
Working capital changed +552.5% from the comparable as-filed period.
Research & development changed +125.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating income changed +515.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Cash & equivalents changed +20.7% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.